Cambrex, a global contract development and manufacturing organization (CDMO) with operations in High Point and Durham, has announced that its stability storage business known as Q1 Scientific will open a new state-of-the-art facility in Durham later this …
A Swedish cancer diagnostics developer is reinventing itself and transplanting its North American headquarters from the Boston area to North Carolina’s booming Research Triangle area to become more efficient and effective. Immunovia said in a July 2 news …
A California medical technology startup plans to expand the Research Triangle Park facility it bought in 2022, adding 50 jobs and spending up to $65 million on the project. Science Corp. in Alameda, Calif., is developing brain-computer interface devices …
TruLab, a provider of technology for overseeing drug clinical trials, has relocated to new offices in Research Triangle Park (RTP) to support its rapid growth and development. The company has signed a two-year lease for 10,000 square feet of space in …
Verona Pharma announced it has received FDA approval for Ohtuvayre (Ensifentrine), a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adult patients. It is the first inhaled product available for the disease and is delivered …
Claradele Pharmaceuticals, a Greenville startup developing a unique immunotherapy for metastatic melanoma, is the 2024 NCBiotech Venture Challenge winner. The Claradele selection marked the pinnacle of a months-long grooming process for North Carolina’s …
Five of the Piedmont Triad region’s most impactful individuals and organizations in the life sciences have been honored with Excellence Awards. The awards were given at Triad BioNight, a celebration of the region’s life sciences industry organized by the …
Millions of consumers know Bayer as the aspirin company. Some even know it’s the Alka-Seltzer company. Investors know it as the German pharmaceutical, life sciences and agricultural giant that bought Monsanto in 2018. Now Bayer is buying a bigger bite of …
As NCBiotech’s Vice President of Talent and Culture Development, I have the privilege of observing and shaping our organization’s culture. On our 40th anniversary, I’ve been reflecting on the critical role that our staff, culture and collaboration play in …
In the largest capital investment ever in North Carolina’s life sciences, Novo Nordisk plans to invest $4.1 billion to expand its fill and finish operations in Johnston County, creating 1,000 new jobs and adding 1.4 million square feet of new manufacturing …
North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring …
The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates. Opus said the new …
Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin), a global specialty pharmaceutical company based in Japan, this week announced that its board of directors approved plans to invest up to $530 million to build a new, state-of-the-art …
Durham-based restor3d this week announced it has received $70 million in financing by closing $55 million in Series A funding by private investors and securing $15 million in debt financing. The designer and manufacturer of 3D-printed orthopedic implants …
Science, innovation and entrepreneurship are the key ingredients in bringing forward new medical therapies and treatment options for patients. But these will never successfully come together at the right time and in the right quantities if they are not …
As we approach North Carolina Biotechnology Center's 40th anniversary, it’s important to consider the unique qualities that distinguish our organization and highlight the collaborative nature of our staff, who generate NCBiotech's contributions to …
A Swiss contract research organization, Solvias, is establishing a cell- and gene-therapy (CGT) testing center in Morrisville, where it plans to employ more than 170 people by the end of 2025. Solvias, founded in 1999 via a management buyout from Novartis, …
Durham-based Deep Blue Medical Advances has been honored with the Angel Capital Association (ACA) 2024 Luis Villalobos Award in the life sciences category. The prestigious award signifies the most ingenious and innovative ideas recently backed by members …
Daniel R. Saban, Ph.D., founder and chief scientific officer of Duke University spinout Piximune Therapeutics was honored with the 2024 Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest association of eye …
The Bezos Center for Sustainable Protein has launched at North Carolina State University. The Bezos Earth Fund awarded NC State $30 million over five years to lead a center of excellence to create a biomanufacturing hub for dietary proteins that are …
